Progyny, Inc.

Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders

Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

What if I purchased Progyny securities? If you purchased securities and suffered losses on your investment, join our investigation now:

Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.

There is no cost or obligation to you.

What is Johnson Fistel Investigating? On September 18, 2024, Progyny revealed in a filing with the U.S. Securities and Exchange Commission that a major client had opted to exercise a 90-day termination option for its services agreement, effective January 1, 2025. The following day, on September 19, 2024, JMP Securities downgraded Progyny from Outperform to Market Perform, citing concerns that the loss of Progyny’s largest client could lead to lower retention rates in the future.

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com.